Company: BIVIW
Filing Date: 2025-08-08
Form Type: 424B5
Source: 0001520138-25-000247
Chunk: 198

Company: BIOVIE INC.
Filing Date: 2025-08-08
Form: 424B5
Chunk 198
---
as a going concern. The financial statements do not include any adjustments that might result from the outcome of this uncertainty.

| 3. | Significant Accounting Policies |

Basis of Presentation – Interim Financial Information

These unaudited interim condensed financial statements
and related notes have been prepared in accordance with accounting principles generally accepted in the United State of America (“U.S.
GAAP”) for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the Securities
and Exchange Commission (the “SEC”) for Interim Reporting. Accordingly, they do not include all of the information and footnotes
required by U.S. GAAP for complete financial statements. The unaudited interim condensed financial statements furnished reflect all adjustments
(consisting of normal recurring accruals) that are, in the opinion of management, considered necessary for a fair presentation of the
results for the interim periods presented. Interim results are not necessarily indicative of the results for the full year. The condensed
balance sheet at June 30, 2024, was derived from audited annual financial statements but does not contain all the footnote disclosures
from the annual financial statements. These unaudited interim condensed financial statements should be read in conjunction with the Company’s
audited financial statements for the fiscal years ended June 30, 2024 and 2023 in our Annual Report on Form 10-K filed with the SEC on
September 30, 2024 (the “2024 Form 10-K”). A summary of significant accounting policies can also be found in those audited
financial statements in the 2024 Form 10-K.

Cash and cash equivalents

Cash and cash equivalents consisted of cash deposits
and money market funds held at a bank and funds held in a brokerage account which included a U.S. treasury money market fund and U.S.
Treasury Bills with original maturities of three months or less.

Investments in U.S. Treasury Bills

Investments in U.S. Treasury Bills with maturities
greater than three months, are accounted for as available-for-sale and are recorded at fair value. Realized gains were included in the
accompanying condensed statements of operations and comprehensive loss from the settlement of available-for-sale investments during the
nine months ended March 31, 2024. The Company had no outstanding investment securities with original maturities of greater than three
months at the time of purchase as of and during the three and nine months ended March 31